Health Notices




4740 NEW ZEALAND GAZETTE, No. 188 10 NOVEMBER 2005

Health

Medicines Act 1981

Consent to the Distribution of a Changed Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Cialis
Active Ingredient: Tadalafil 10mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturers: Eli Lilly and Co, Lilly Technology Centre, Indianapolis, Indiana, United States of America
Eli Lilly and Company Limited, Basingstoke, Hampshire, United Kingdom

Product: Cialis
Active Ingredient: Tadalafil 20mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturers: Eli Lilly and Co, Lilly Technology Centre, Indianapolis, Indiana, United States of America
Eli Lilly and Company Limited, Basingstoke, Hampshire, United Kingdom

Dated this 7th day of November 2005.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go7520

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Foradil Certihaler
Active Ingredient: Formoterol fumarate 10µg/dose
Dosage Form: Powder for inhalation
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: SkyePharma Production SAS, Saint Quentin Fallavier Cedex, France

Product: Solian
Active Ingredient: Amisulpride 100mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Sanofi Winthrop Industrie, Colomiers, France

Product: Viread
Active Ingredient: Tenofovir disoproxil fumarate 300mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Muir Hutchison Limited
Manufacturers: Altana Pharma Oranienburg GmbH, Oranienburg, Germany
Patheon Inc, Mississauga, Ontario, Canada

Dated this 7th day of November 2005.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go7521

Public Finance Act 1989

Notice of Publication of Annual Report—Health and Disability Commissioner

Pursuant to section 44A of the Public Finance Act 1989, notice is hereby given that the Health and Disability Commissioner has delivered to the Minister of Health his annual report for the year ended 30 June 2005, containing his financial statements and audit report for the same period.

The Health and Disability Commissioner has, with the consent of the Minister of Health, published the annual report.

Dated this 2nd day of November 2005.

PETE HODGSON, Minister of Health.

go7344



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2005, No 188


Gazette.govt.nz PDF NZ Gazette 2005, No 188





✨ LLM interpretation of page content

🏥 Consent to the Distribution of a Changed Medicine

🏥 Health & Social Welfare
7 November 2005
Medicines Act 1981, Cialis, Tadalafil, Eli Lilly and Company
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
7 November 2005
Medicines Act 1981, Foradil Certihaler, Solian, Viread, Novartis, Pharmacy Retailing, Muir Hutchison
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Notice of Publication of Annual Report—Health and Disability Commissioner

🏥 Health & Social Welfare
2 November 2005
Public Finance Act 1989, Health and Disability Commissioner, Annual Report
  • PETE HODGSON, Minister of Health